Principal Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$495M Sell
881,189
-87,757
-9% -$56.3M 0.26% 74
2025
Q4
$656M Sell
968,946
-346,776
-26% -$236M 0.33% 63
2025
Q3
$841M Buy
1,315,722
+187,967
+17% +$114M 0.42% 45
2025
Q2
$605M Buy
1,127,755
+1,753
+0.2% +$838K 0.32% 62
2025
Q1
$473M Buy
1,126,002
+414,802
+58% +$180M 0.27% 85
2024
Q4
$294M Sell
711,200
-19,270
-3% -$8.45M 0.16% 128
2024
Q3
$369M Sell
730,470
-23,646
-3% -$11.5M 0.2% 109
2024
Q2
$367M Sell
754,116
-8,852
-1% -$4.44M 0.22% 98
2024
Q1
$412M Sell
762,968
-18,400
-2% -$10.1M 0.24% 92
2023
Q4
$434M Sell
781,368
-34,495
-4% -$16.2M 0.28% 85
2023
Q3
$357M Buy
815,863
+11,315
+1% +$5.64M 0.26% 90
2023
Q2
$404M Sell
804,548
-82,966
-9% -$39.8M 0.28% 89
2023
Q1
$444M Sell
887,514
-153,931
-15% -$73.7M 0.32% 74
2022
Q4
$425M Sell
1,041,445
-156,040
-13% -$60.6M 0.32% 82
2022
Q3
$390M Buy
1,197,485
+604,651
+102% +$222M 0.31% 82
2022
Q2
$208M Sell
592,834
-256,163
-30% -$104M 0.15% 145
2022
Q1
$464M Sell
848,997
-68,026
-7% -$35.8M 0.29% 82
2021
Q4
$602M Sell
917,023
-109,355
-11% -$68.6M 0.36% 61
2021
Q3
$638M Sell
1,026,378
-57,698
-5% -$38.8M 0.42% 50
2021
Q2
$685M Sell
1,084,076
-33,148
-3% -$18.3M 0.44% 47
2021
Q1
$547M Sell
1,117,224
-20,560
-2% -$10.3M 0.38% 54
2020
Q4
$569M Sell
1,137,784
-48,634
-4% -$21.8M 0.42% 53
2020
Q3
$466M Sell
1,186,418
-55,417
-4% -$20.5M 0.39% 56
2020
Q2
$410M Sell
1,241,835
-2,175
-0.2% -$630K 0.36% 66
2020
Q1
$301M Buy
1,244,010
+48,769
+4% +$12.7M 0.33% 80
2019
Q4
$312M Buy
1,195,241
+12,988
+1% +$3.42M 0.26% 101
2019
Q3
$321M Sell
1,182,253
-7,649
-0.6% -$2.13M 0.28% 95
2019
Q2
$328M Buy
1,189,902
+113,007
+10% +$27.8M 0.29% 89
2019
Q1
$241M Buy
1,076,895
+289,063
+37% +$59.7M 0.22% 111
2018
Q4
$147M Buy
787,832
+291,795
+59% +$59.8M 0.16% 161
2018
Q3
$124M Buy
496,037
+328,786
+197% +$79.8M 0.11% 220
2018
Q2
$36.5M Buy
167,251
+28,838
+21% +$5.94M 0.03% 501
2018
Q1
$26.5M Sell
138,413
-1,414
-1% -$261K 0.03% 631
2017
Q4
$21.9M Buy
139,827
+1,046
+0.8% +$165K 0.02% 756
2017
Q3
$21.6M Sell
138,781
-6,994
-5% -$1.11M 0.02% 729
2017
Q2
$23.5M Buy
145,775
+2,379
+2% +$386K 0.02% 680
2017
Q1
$22.2M Sell
143,396
-222,135
-61% -$30.6M 0.03% 657
2016
Q4
$42.9M Buy
365,531
+1,097
+0.3% +$125K 0.05% 354
2016
Q3
$41.1M Buy
364,434
+12,539
+4% +$1.32M 0.05% 353
2016
Q2
$32.7M Buy
351,895
+40,504
+13% +$3.48M 0.05% 392
2016
Q1
$24.4M Buy
311,391
+15,357
+5% +$1.11M 0.04% 495
2015
Q4
$21.6M Buy
296,034
+5,318
+2% +$379K 0.03% 532
2015
Q3
$21.6M Sell
290,716
-2,633
-0.9% -$189K 0.03% 515
2015
Q2
$18.8M Buy
293,349
+9,367
+3% +$648K 0.03% 611
2015
Q1
$21.9M Buy
283,982
+11,196
+4% +$871K 0.03% 506
2014
Q4
$20.2M Sell
272,786
-14,786
-5% -$1.04M 0.03% 535
2014
Q3
$16.9M Sell
287,572
-2,236
-0.8% -$141K 0.03% 589
2014
Q2
$19.4M Buy
289,808
+25,864
+10% +$1.64M 0.03% 542
2014
Q1
$16M Sell
263,944
-6,372
-2% -$380K 0.03% 629
2013
Q4
$14.4M Sell
270,316
-17,800
-6% -$937K 0.03% 658
2013
Q3
$14.4M Buy
288,116
+39,974
+16% +$1.92M 0.03% 607
2013
Q2
$11.1M Buy
+248,142
New +$10.8M 0.02% 700

Other funds holding IDXX

Principal Financial Group's IDXX Position: Q1 2026 in Review

Principal Financial Group reduced its Idexx Laboratories (IDXX) stake by 9.1% in Q1 2026, selling an estimated $56.3M and leaving 881,189 shares worth $495M. The position accounts for 0.26% of the portfolio, ranked #74.

Principal Financial Group first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $841M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Principal Financial Group held 881,189 shares of Idexx Laboratories worth $495M as of Q1 2026.
  • Principal Financial Group sold 87,757 Idexx Laboratories shares in Q1 2026, an estimated $56.3M.
  • Idexx Laboratories made up 0.26% of Principal Financial Group's portfolio in Q1 2026, its #74 holding.
  • Principal Financial Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Principal Financial Group's Idexx Laboratories position peaked at $841M in Q3 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.